文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤切除术中脑室开放时局部放疗是否可行

Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases?
PubMed 文献 · Radiat Oncol · 2020-12-10

本研究基于2009—2017年125例脑转移瘤切除术后接受局部大分割立体定向放疗(HFSRT)的患者数据,评估术中脑室开放(VO)对预后的影响。结果显示VO组14例(11.2%)与无VO组在软脑膜播散(LMD)、总生存、局部复发及远处复发方面均无显著差异,VO未影响HFSRT结局,局部HFSRT可独立于VO作为瘤床局部治疗选择。

要点

  • 脑转移瘤切除术后局部HFSRT可独立于术中脑室开放情况实施。
  • VO组LMD发生率为0,无VO组为7例,两组差异无统计学意义(p=0.371)。
  • VO组 distant intraventricular recurrence 发生率略高(14.3% vs. 2.7%,p<0.01)。

核心结论

  • 神经外科切除术中脑室开放未影响脑转移瘤患者接受瘤床HFSRT后的结局。
  • 接受局部HFSRT的VO患者LMD发生率未增加,HFSRT可独立于VO作为瘤床局部治疗。

研究设计与样本

  • 回顾性分析2009—2017年单中心连续125例脑转移瘤切除术后接受HFSRT的患者数据。
  • 根据术中是否发生脑室开放(VO)分组,评估LMD、总生存(OS)、局部复发(LC)和远处复发。

主要发现

  • 125例中14例(11.2%)术中发生脑室开放。
  • VO组无患者发生LMD,无VO组7例发生LMD(p=0.371)。
  • OS(p=0.817)、LC(p=0.524)和远处复发(p=0.488)与VO无关。
  • VO组 distant intraventricular recurrence 发生率略高于无VO组(14.3% vs. 2.7%,p<0.01)。

关键数值与推荐

  • VO组LMD发生率为0%(0/14),无VO组为7例(p=0.371)。
  • VO组 distant intraventricular recurrence 发生率为14.3%,无VO组为2.7%(p<0.01)。
  • OS组间比较p=0.817,LC组间比较p=0.524,远处复发组间比较p=0.488。

临床怎么用

  • 脑转移瘤切除术后瘤床局部HFSRT的适应证选择可不因术中脑室开放而排除。
  • VO患者术后行局部HFSRT时,仍需关注 distant intraventricular recurrence 风险。

局限性

  • 回顾性单中心分析,VO组样本量较小(14例)。
  • VO组LMD事件数为0,相关比较的统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Local hypofractionated stereotactic radiotherapy (HFSRT) of the resection cavity is emerging as the standard of care in the treatment of patients with a limited number of brain metastases as it warrants less neurological impairment compared to whole brain radiotherapy. In periventricular metastases surgical resection can lead to an opening of the ventricles and subsequently carries a potential risk of cerebrospinal tumour cell dissemination. The aim of this study was to assess whether local radiotherapy of the resection cavity is viable in these cases. METHODS: From our institutional database we analyzed the data of 125 consecutive patients with resected brain metastases treated in our institution with HFSRT between 2009 and 2017. The incidence of LMD, overall survival (OS), local recurrence (LC) and distant recurrence were evaluated depending on ventricular opening (VO) during surgery. RESULTS: From all 125 patients, the ventricles were opened during surgery in 14 cases (11.2%). None of the patients with VO and 7 patients without VO during surgery developed LMD (p = 0.371). OS (p = 0.817), LC (p = 0.524) and distant recurrence (p = 0.488) did not differ in relation to VO during surgical resection. However, the incidence of distant intraventricular recurrence was slightly increased in patients with VO (14.3% vs. 2.7%, p < 0.01). CONCLUSION: VO during neurosurgical resection did not affect the outcome after HFSRT of the resection cavity in patients with brain metastases. Particularly, the incidence of LMD was not increased in patients receiving local HFSRT after VO. HFSRT can therefore be offered independently of VO as a local treatment of tumor bed after resection of brain metastases.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Scharl S, Kessel KA, Diehl C, et al. Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases? Radiat Oncol. 2020. PMID: 33303000. doi:10.1186/s13014-020-01725-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。